PRGO PERRIGO Co plc

NEUTRAL Impact: 2/10 144
Horizon immediate Filed May 28, 2026 Processed 19d 13h ago SEC 0001959173-26-004094
Form 144 — notice of proposed sale of securities
Latest settled — T+5d
PRGO ▼ -4.38% at T+5d
NEUTRAL call ✗ call lost -4.38% · α vs SPY -4.69% · entry $11.15 → $10.66
Next anchor: T+20d in 9d
Currently $10.67 · -4.30% from $11.15 entry
Entry anchored
May 28, 2026
via day open
T+1d
-0.90%
call -0.90% · α -1.14%
$11.05
settled 19d ago
T+5d
-4.38%
call -4.38% · α -4.69%
$10.66
settled 13d ago
T+20d
call — · α —
in 9d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Former director Jeffrey B. Kindler filed a Form 144 notice of intent to sell 14,357 common shares of Perrigo (PRGO), with an estimated aggregate market value of $164,242.28 based on the filing date price of approximately $11.44/share. The shares were acquired through restricted stock vesting events spanning May 2023 to May 2026, and the sale is to be executed via Fidelity Brokerage Services LLC. At Perrigo's current market cap of ~$1.5B, this represents a de minimis proposed sale (~0.01% of shares outstanding) by a former director with no current executive role — the filing is routine and unlikely to carry informational content about the company's operations or outlook.

Actionable Insight

This is a routine, small-dollar Form 144 by a former director selling RSU-sourced shares. No material trading signal — the filing does not warrant a trading response. Monitor upcoming quarterly results (next 10-Q) for fundamental operating trends, not insider sale patterns.

Key Facts

  • Form 144 filed by Jeffrey B. Kindler, a former director of Perrigo (no longer serving on the board).
  • Proposed sale of 14,357 common shares at an estimated aggregate value of approximately $164,242.28.
  • Shares were acquired via restricted stock vesting on 05/17/2023 (852 shares), 05/15/2024 (4,557 shares), 05/14/2025 (5,150 shares), and 05/01/2026 (3,798 shares) — all compensation-based.
  • Sale is to be executed through Fidelity Brokerage Services LLC as agent.
  • The proposed sale amounts to roughly 0.01% of Perrigo's ~135M estimated shares outstanding.

Financial Impact

~$164,000 gross proceeds, representing a ~0.01% dilution of outstanding shares — immaterial.

Risk Factors

  • Form 144 is advance notice of intent to sell — the sale may not be executed.
  • Former director status and small share count limit the informational value of this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (10 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004094
Document: 0001959173-26-004094-index.html0001959173-26-004094
Document: 0001959173-26-004094.txt0001959173-26-004094
5 reports for PRGO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PRGO — sortable, filterable
Type Now
May 28, 2026
19d ago
144
NEUTRAL ★ 2/10
$11.15 $10.66▼ −4.38%▼ −4.69%$10.67 (−4.30%)
Apr 22, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$11.68 $11.29▼ −3.36%▼ −4.83%$10.67 (−8.66%)
Apr 3, 2026
10w ago
DEFA14A
NEUTRAL ★ 2/10
$10.56 $11.31▲ +7.08%▲ +2.95%$10.67 (+1.02%)
Mar 20, 2026
12w ago
DEFA14A
NEUTRAL ★ 2/10
$9.23 $9.52▲ +3.14%▲ +5.29%$10.67 (+15.58%)
Feb 26, 2026
15w ago
8-K
BEARISH ★ 8/10
$14.08 $11.14▲ +20.88%▲ +19.75%$10.67 (+24.23%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 5h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access